BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23001699)

  • 1. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.
    Yang JJ; Yang JH; Kim J; Ma SH; Cho LY; Ko KP; Shin A; Choi BY; Kim HJ; Han DS; Eun CS; Song KS; Kim YS; Chang SH; Shin HR; Kang D; Yoo KY; Park SK
    Int J Cancer; 2013 May; 132(9):2148-56. PubMed ID: 23001699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.
    Jang J; Ma SH; Ko KP; Choi BY; Yoo KY; Park SK
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):470-476. PubMed ID: 31740519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer.
    López-Carrillo L; Torres-López J; Galván-Portillo M; Muñoz L; López-Cervantes M
    Eur J Cancer; 2004 Jul; 40(11):1752-9. PubMed ID: 15251166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
    Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
    World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma.
    Barisione G; Fabbi M; Gino A; Queirolo P; Orgiano L; Spano L; Picasso V; Pfeffer U; Mosci C; Jager MJ; Ferrini S; Gangemi R
    JAMA Ophthalmol; 2015 Sep; 133(9):1013-21. PubMed ID: 26068448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of gastric cancer, HLA-DQA1, and infection with Helicobacter pylori CagA+ and VacA+ in a Mexican population.
    Garza-González E; Bosques-Padilla FJ; Pérez-Pérez GI; Flores-Gutiérrez JP; Tijerina-Menchaca R
    J Gastroenterol; 2004 Dec; 39(12):1138-42. PubMed ID: 15622476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer.
    Tian W; Jia Y; Yuan K; Huang L; Nadolny C; Dong X; Ren X; Liu J
    Helicobacter; 2014 Feb; 19(1):9-16. PubMed ID: 24118166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.